The Market Access & Patient Advocacy Subcommittee strives to:
- Educate the cell therapy industry on pre-commercialization reimbursement considerations.
and recruit leaders in industry who have late-stage development products and
have addressed regulatory and manufacturing hurdles.
Projects and Objectives
- Describe reimbursement policies on a regional basis to include the UK, Australia and USA.
- Organize an ISCT webinar on reimbursement considerations.
|Gerhard Bauer, PhD
Sacramento, CA, United States
Miguel Forte, MD, PhD
Derek Hei, PhD
Cambridge, MA, United States
|Chris McClain, PhD
Be The Match BioTherapies
Minneapolis, MN, United States
|Erika Siren, PhD
Harvard Medical School
Boston, MA, United States